USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
MITOHEALTH, INC.
Address:
645 Meeting Street
CHARLESTON, SC 29403-4279
Phone:
N/A
URL:
N/A
EIN:
127125669
DUNS:
832752112
Number of Employees:
2
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $544,991.00 2
SBIR Phase II $1,608,122.00 1

Award List:

Inducers of Mitochondrial Biogenesis

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$312,053.00
Agency:
HHS
Principal Investigator:
Craig C. Beeson – 843-876-5091
Abstract:
DESCRIPTION (provided by applicant): The long-term goal of this project is to identify and develop drugs that induce mitochondrial biogenesis. A variety of diverse acute insults such as ischemia/reperfusion (I/R), drug, toxicant, and trauma lead to mitochondrial dysfunction and results in cell… More

High Throughput Mitochondrial Nephrotoxicant Assay

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$1,608,122.00
Agency:
HHS
Principal Investigator:
Craig C. Beeson – 843-876-5091
Abstract:
DESCRIPTION (provided by applicant): The kidney is a target of toxicity from drugs, and industrial and environmental chemicals because of its high blood flow, numerous transporters, and reliance on aerobic metabolism. Not surprisingly, mitochondria are acommon intracellular target of chemicals in… More

Development of a lasmiditan analogue for treatment of acute kidney injury

Award Year / Program / Phase:
2014 / SBIR / Phase I
Award Amount:
$232,938.00
Agency:
HHS
Principal Investigator:
Craig C. Beeson – 843-876-5091
Abstract:
DESCRIPTION (provided by applicant): The long-term goal of this project is to develop a safe and efficacious therapeutic small molecule for treatment of acute kidney injury (AKI). AKI results from diverse insults such as sepsis, ischemia-reperfusion (I/R)or nephrotoxicant exposure and nearly half of… More